Your browser doesn't support javascript.
loading
Addressing disparities and challenges in underserved patient populations with metastatic breast cancer in Europe.
Vrdoljak, Eduard; Gligorov, Joseph; Wierinck, Lieve; Conte, PierFranco; De Grève, Jacques; Meunier, Françoise; Palmieri, Carlo; Travado, Luzia; Walker, Andrew; Wiseman, Theresa; Wuerstlein, Rachel; Alba, Emilio; Biurrún, Concepción; D'Antona, Rosanna; Sola-Morales, Oriol; Ubaysi, Catherine; Ventura, Roberta; Cardoso, Fatima.
Afiliação
  • Vrdoljak E; Department of Oncology, University Hospital Center Split, School of Medicine, University of Split, Spinciceva 1, Split, HR-21.000, Croatia. Electronic address: edo.vrdoljak@gmail.com.
  • Gligorov J; Medical Oncology Department, APHP Tenon, 4 Rue de La Chine, Paris, 75020, France. Electronic address: joseph.gligorov@tnn.aphp.fr.
  • Wierinck L; Brussels, Belgium. Electronic address: lievewierinck@icloud.com.
  • Conte P; Department of Surgery, Oncology and Gastroenterology, University of Padova and Medical Oncology 2, IOV - Istituto Oncologico Veneto I.R.C.C.S., Via Giustiniani 2, Padova, 35124, Italy. Electronic address: pierfranco.conte@unipd.it.
  • De Grève J; Departments of Genetics and Oncology, Universitair Ziekenhuis (UZ) Brussel, Campus Jette Laarbeeklaan 101, Brussels, 1090, Belgium. Electronic address: jacques.degreve@uzbrussel.be.
  • Meunier F; Federation of European Academies of Medicine, Rue d' Egmont 11, Brussels, 1000, Belgium. Electronic address: doctormeunier@fmeunier.eu.
  • Palmieri C; The Clatterbridge Cancer Center NHS Foundation Trust, 66 Pembroke Place, Liverpool, L7 8YA, UK; Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, UK. Electronic address: C.Palmieri@liverpool.ac.uk.
  • Travado L; Champalimaud Clinical Center/Champalimaud Foundation, Av. Brasília, Lisbon, 1400-038, Portugal. Electronic address: luzia.travado@fundacaochampalimaud.pt.
  • Walker A; Salus Alba Limited, 20-23 Woodside Place, Glasgow, G3 7QL, United Kingdom. Electronic address: andrew@salusalba.com.
  • Wiseman T; The Royal Marsden NHS Foundation Trust, Applied Health Research Department, Fulham Road, London, SW3 6JJ, UK. Electronic address: Theresa.Wiseman@rmh.nhs.uk.
  • Wuerstlein R; Breast Center, University Hospital Munich (LMU), CCC Munich, Marchioninistraße 15, Munich, D-81377, Germany. Electronic address: Rachel.Wuerstlein@med.uni-muenchen.de.
  • Alba E; University Hospital Virgen de La Victoria, Campus de Teatinos, S/N, Málaga, 29010, Spain. Electronic address: ealbac@uma.es.
  • Biurrún C; Federación Española de Cáncer de Mama (FECMA), Carrer de Tusset 32, Barcelona, 08006, Spain. Electronic address: cbiurrun57@gmail.com.
  • D'Antona R; Europa Donna Italia, Via Conservatorio 15, Milano, 20122, Italy. Electronic address: rosannadantona@europadonna.it.
  • Sola-Morales O; Health Innovation Technology Transfer 'Foundation (FHITT), Aragó 60 Ppal 1a, Barcelona, E-08015, Spain. Electronic address: osola@fhitt.org.
  • Ubaysi C; Patients en Réseau, Paris, 75006, France. Electronic address: catherine.ubaysi@gmail.com.
  • Ventura R; ABC Global Alliance, C/o Champalimaud Foundation, Av. Brasília, Lisbon, 1400-038, Portugal. Electronic address: rventura@abcglobalalliance.org.
  • Cardoso F; ABC Global Alliance, C/o Champalimaud Foundation, Av. Brasília, Lisbon, 1400-038, Portugal; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. Electronic address: fatimacardoso@fundacaochampalimaud.pt.
Breast ; 55: 79-90, 2021 Feb.
Article em En | MEDLINE | ID: mdl-33360479
People with metastatic breast cancer face many challenges and disparities in obtaining optimal cancer care. These challenges are accentuated in underserved patient populations across Europe, who are less likely to receive quality healthcare for reasons including socioeconomic inequalities, educational or cultural status, or geographic location. While there are many local and national initiatives targeted to address these challenges, there remains a need to reduce disparities and improve access to healthcare to improve outcomes, with a focus on multidisciplinary stakeholder engagement. In October 2019, a range of experts in metastatic breast cancer, including healthcare professionals, patient representatives, policymakers and politicians, met to discuss and prioritize the critical needs of underserved patient populations with metastatic breast cancer in Europe. Six key challenges faced by these communities were identified: the need for amplification of the metastatic breast cancer patient voice, better and wider implementation of high-quality guidelines for metastatic breast cancer, more collaboration between stakeholders, tailored support for patients from different cultural and ethnic backgrounds, improved data sharing, and work-related issues. The Expert Panel then conceived and discussed potential actionable goals to address each key challenge. Their conclusions present a set of interrelated approaches to address the different challenges and could serve as the basis for concerted improvement of the lives of patients with metastatic breast cancer in Europe.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article